These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 29574651)

  • 1. D-dimer predicts postoperative recurrence and prognosis in patients with liver metastasis of colorectal cancer.
    Watanabe A; Araki K; Harimoto N; Kubo N; Igarashi T; Ishii N; Yamanaka T; Hagiwara K; Kuwano H; Shirabe K
    Int J Clin Oncol; 2018 Aug; 23(4):689-697. PubMed ID: 29574651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Codon 13 KRAS mutation predicts patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.
    Margonis GA; Kim Y; Sasaki K; Samaha M; Amini N; Pawlik TM
    Cancer; 2016 Sep; 122(17):2698-707. PubMed ID: 27244540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Clinical Factor, D-Dimer Platelet Multiplication, May Predict Postoperative Recurrence and Prognosis for Patients with Cholangiocarcinoma.
    Watanabe A; Araki K; Hirai K; Kubo N; Igarashi T; Tsukagoshi M; Ishii N; Hoshino K; Kuwano H; Shirabe K
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):886-891. PubMed ID: 27444106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic monitoring of circulating tumor DNA to predict prognosis and efficacy of adjuvant chemotherapy after resection of colorectal liver metastases.
    Wang DS; Yang H; Liu XY; Chen ZG; Wang Y; Fong WP; Hu MT; Zheng YC; Zheng Y; Li BK; Yuan YF; Chen G; Pan ZZ; Song L; Li YH; Xu RH
    Theranostics; 2021; 11(14):7018-7028. PubMed ID: 34093868
    [No Abstract]   [Full Text] [Related]  

  • 5. Significance of Herpesvirus Entry Mediator Expression in Human Colorectal Liver Metastasis.
    Sasaki Y; Hokuto D; Inoue T; Nomi T; Yoshikawa T; Matsuo Y; Koyama F; Sho M
    Ann Surg Oncol; 2019 Nov; 26(12):3982-3989. PubMed ID: 31313042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy.
    Sakamoto Y; Miyamoto Y; Beppu T; Nitta H; Imai K; Hayashi H; Baba Y; Yoshida N; Chikamoto A; Baba H
    Anticancer Res; 2015 Apr; 35(4):2359-68. PubMed ID: 25862901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total tumour volume as a prognostic factor in patients with resectable colorectal cancer liver metastases.
    Tai K; Komatsu S; Sofue K; Kido M; Tanaka M; Kuramitsu K; Awazu M; Gon H; Tsugawa D; Yanagimoto H; Toyama H; Murakami S; Murakami T; Fukumoto T
    BJS Open; 2020 Jun; 4(3):456-466. PubMed ID: 32277807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphatic Invasion is an Independent Adverse Prognostic Factor in Patients with Colorectal Liver Metastasis.
    de Ridder JA; Knijn N; Wiering B; de Wilt JH; Nagtegaal ID
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S638-45. PubMed ID: 25986865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of serum D-dimer, fibrinogen, and CA19-9 for postoperative monitoring and survival prediction in resectable pancreatic carcinoma.
    Cao J; Fu Z; Gao L; Wang X; Cheng S; Wang X; Ren H
    World J Surg Oncol; 2017 Feb; 15(1):48. PubMed ID: 28219450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Role of BRAF Mutations in Colorectal Cancer Liver Metastases.
    Pikoulis E; Margonis GA; Andreatos N; Sasaki K; Angelou A; Polychronidis G; Pikouli A; Riza E; Pawlik TM; Antoniou E
    Anticancer Res; 2016 Sep; 36(9):4805-11. PubMed ID: 27630332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of fibrinogen and D-dimer-fibrinogen ratio in resectable gastrointestinal stromal tumors.
    Cai HX; Li XQ; Wang SF
    World J Gastroenterol; 2018 Nov; 24(44):5046-5056. PubMed ID: 30510379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of repeat hepatectomy for recurrence following curative hepatectomy for colorectal liver metastases: A Retrospective Cohort Study of 128 patients.
    Hashimoto M; Kobayashi T; Ishiyama K; Ide K; Ohira M; Tahara H; Kuroda S; Hamaoka M; Iwako H; Okimoto M; Ohdan H
    Int J Surg; 2016 Dec; 36(Pt A):96-103. PubMed ID: 27741421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraoperative blood loss independently predicts survival and recurrence after resection of colorectal cancer liver metastasis.
    Jiang W; Fang YJ; Wu XJ; Wang FL; Lu ZH; Zhang RX; Ding PR; Fan WH; Pan ZZ; De-Sen Wan
    PLoS One; 2013; 8(10):e76125. PubMed ID: 24098431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAS Mutation is Associated with Unsalvageable Recurrence Following Hepatectomy for Colorectal Cancer Liver Metastases.
    Okuno M; Goumard C; Kopetz S; Vega EA; Joechle K; Mizuno T; Omichi K; Tzeng CD; Chun YS; Vauthey JN; Conrad C
    Ann Surg Oncol; 2018 Aug; 25(8):2457-2466. PubMed ID: 29786130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative Plasma Fibrinogen and D-dimer as Prognostic Biomarkers for Non-Muscle-Invasive Bladder Cancer.
    Li X; Shu K; Zhou J; Yu Q; Cui S; Liu J; Zhou R; Ding D
    Clin Genitourin Cancer; 2020 Feb; 18(1):11-19.e1. PubMed ID: 31787543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic impact of resection margin status varies according to the genetic and morphological evaluation (GAME) score for colorectal liver metastasis.
    Wang HW; Wang LJ; Jin KM; Bao Q; Li J; Wang K; Xing BC
    J Surg Oncol; 2021 Sep; 124(4):619-626. PubMed ID: 34081792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of KRAS Mutation on Long-Term Outcomes of Patients Undergoing Hepatic Resection for Colorectal Liver Metastases.
    Margonis GA; Spolverato G; Kim Y; Karagkounis G; Choti MA; Pawlik TM
    Ann Surg Oncol; 2015 Dec; 22(13):4158-65. PubMed ID: 26077912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum D-dimer as a prognostic marker in patients undergoing radiofrequency ablation of colorectal liver metastasis.
    Tellioglu G; Agcaoglu O; Siperstein A; Berber E
    J Invest Surg; 2012 Oct; 25(5):295-300. PubMed ID: 23020269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new strategy based on fluorodeoxyglucose-positron emission tomography for managing liver metastasis from colorectal cancer.
    Watanabe A; Harimoto N; Araki K; Yoshizumi T; Arima K; Yamashita Y; Baba H; Tetsuya H; Kuwano H; Shirabe K
    J Surg Oncol; 2018 Dec; 118(7):1088-1095. PubMed ID: 30261101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-hepatectomy dynamic circulating tumor DNA to predict pathologic response to preoperative chemotherapy and post-hepatectomy recurrence in patients with colorectal liver metastases.
    Liu M; Bao Q; Zhao T; Huang L; Zhang D; Wang Y; Yan X; Wang H; Jin K; Liu W; Wang K; Xing B
    Hepatol Int; 2024 Jun; 18(3):1029-1039. PubMed ID: 38427145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.